Baxter International Inc
BAX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| z%j | LOCK|z^>$ | LOCK|&D |
Baxter Earnings: Maintained 2026 Outlook Relieves Market
Baxter's first-quarter results included a 1% sales decline on an organic basis, against a tough comparable period, and adjusted earnings per share of $0.36 on a continuing basis, which came in above FactSet consensus of $0.31. Management maintained its guidance for 2026.
